Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History
December 11, 2025
Endpoints News is calling December 10 the busiest day ever in biotech, with the most follow-on proceeds in a single day. A record-setting $3.2B in biotech follow-on stock offerings were sold, indicating public investors’ appetite for biotech investment. From late Tuesday evening into Wednesday morning, eight biotechs priced sales of new stocks, and seven of those companies increased their offering sizes to meet demand.
Utah’s own Denali Therapeutics was among the biotechs raising funds.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
